Juvenile Myelomonocytic Leukemia — Trials

Juvenile Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Masonic Cancer Center, University of Minnesota
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05849662	A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia	recruiting	Phase 1 / Phase 2	58	Therapeutic Advances in Childhood Leukemia ConsortiumOTHER	1	Sep 4, 2026	clinicaltrials
NCT04726241	The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study	recruiting	Phase 1 / Phase 2	960	PedAL BCU, LLCOTHER